Vol.

No.

October 21, 2022Oct 21, 2022

DOWNLOAD THE PDF

ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA

Cover Story

Conversation with The Cancer Letter

ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA

By Paul Goldberg

Researchers at the Gene Editing Institute at ChristianaCare have been moving forward with an effort to use CRISPR-directed gene editing technology in the clinic.

Free

Cleanup continues for cancer clinics after Hurricane Ian tore through Fort Myers

By Jacquelyn Cobb

White House

Jill Biden at Sylvester: “We will speed up this next phase in ending breast cancer as we know it”

By Matthew Bin Han Ong

Free Guest Editorial

Preventing the “Killing Twice Effect”: What we can do to support Ukrainian oncology professionals during the war

By Nataliya Kovalchuk, Yuliia Lozko, Yuliia Severyn, Andriy Beznosenko, Ruslan Zelinsky, Nelya Melnitchouk, Viktor Iakovenko, Roman Kowalchuk and Natalka Suchowerska

NAM new members include Sharpless, Tuveson, Fowler, Karikó, Mackall, Polyak, Campbell, Eaves, Shi, Frederick, Glazer, Gutmann, Markert, Mischel, Quackenbush, Rathmell

Free In the Archives

Bone marrow transplantation: Dottie Thomas, primary sources, and controversies

In Brief

Pediatric oncologist Oksana Leontyeva killed in Russian rocket attack on Kyiv

Sudhir Srivastava wins the Don Listwin Award for cancer prevention, early detection

MSK and MD Anderson presidents place friendly Twitter bet on Astros vs. Yankees

Don Dizon named vice chair for DEI, professional integrity at SWOG

Nicole Gormley named acting associate director for oncology endpoint development at FDA’s OCE

Northwell receives gift from trustee Roy J. Zuckerberg to create cancer hospital and cancer campus on Long Island

Yuan Yuan named director of Breast Oncology at Cedars-Sinai

Terry Hyslop named Cancer Risk and Control Program co-leader and director of Center for Health Equity at SKCC

Zelig Eshhar receives Richard V. Smalley Memorial Award & Lectureship

Candace Johnson receives Advocacy in Action Award

USC Norris shares $500K federal grant with Chinatown Service Center to improve equity in cervical cancer screening, treatment

MD Anderson and WHO establish international collaboration to reduce women’s cancers

Miami Cancer Institute, ChristianaCare, Ochsner, OSUCCC – James, Massey named ACCC 2022 Innovator Award winners

NCCN guidelines for patients win Excellence in Cancer Patient Education award from CPEN

Anna D. Barker receives inaugural Beacon Award for Women in Oncology

Funding Opportunities

Harrington Discovery Institute at UH and Case Western Reserve School of Medicine open call for 2023 Harrington-MSTP Scholar Award

Clinical Roundup

Phase III pancreatic cancer study launched with OS primary endpoint for patients receiving MRI-guided ablative radiation therapy

Baylor study points to strategy to suppress prostate cancer growth

Researchers discover how bacteria make pancreatic cancer cells grow and move

Drugs & Targets

FDA publishes final guidance on drug development for AML

FDA publishes draft guidance on characterizing, collecting, and reporting immune-mediated adverse reactions

FDA publishes draft guidance on tissue agnostic drug development in oncology

Pluvicto receives positive CHMP opinion for prostate cancer

Libtayo receives positive CHMP opinion for advanced cervical cancer

CRADA with NCI to expand development of DAY101

HOOKIPA, Roche form collaboration to develop arenaviral immunotherapy for KRAS-mutated cancers

Jazz Pharmaceuticals and Zymeworks agree to develop, commercialize zanidatamab

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 41 - November 07, 2025